With reference to the above captioned subject we wish to inform you that there were few additions made in the Q4-FY18 Earnings Presentation May 2018 after we submitted the same to the Stock Exchanges on 1st June, 2018. In view of the same, we hereby enclose the revised Earning Presentation for the fourth quarter and year ended 31st March 2018
Pursuant to Regulations 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a copy of Investor Presentation of June, 2018.
Sub.: Intimation of presentation made to analyst / institutional investors Ref.: Regulation 30 & Regulation 46 of SEBI (LODR) Regulations, 2015 In accordance with Regulation 30 and Regulation 46 of SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015, please find enclosed herewith updated investor presentation. Kindly take the same on record and acknowledge.
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find attached updated Investor presentation to be discussed during investor/Analyst meetings.
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing and Disclosure Requirements)Regulation,2015, we give advance intimation to inform the stock exchange that the Company wishes to make Investor Presentation in regards to company products, different verticals ,acquisition and financial highlights.
Please find enclosed herewith the presentation that will be made at the Investor/ Analyst Meet of Bayer CropScience Limited being held on Thursday, June 14, 2018. Request you to please take the said presentation on record and upload onto the BSE website. Kindly acknowledge receipt of the same.